GlaxoSmithKline PLC (GSK) — Cash Flow-to-Debt Ratio
GlaxoSmithKline PLC (GSK) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of GBX2.22 Billion could theoretically repay 0% of its total liabilities (GBX45.59 Billion) in one year. See free cash flow generation of GlaxoSmithKline PLC to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlaxoSmithKline PLC Cash Flow-to-Debt Ratio (1991–2024)
Historical debt coverage capacity for GlaxoSmithKline PLC across 35 annual periods. Also explore net asset momentum of GlaxoSmithKline PLC to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GlaxoSmithKline PLC (1991–2024)
Year-by-year debt coverage analysis for GlaxoSmithKline PLC. For market capitalisation and broader financial context, see GSK market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | GBX6.55 Billion | GBX46.38 Billion | ▼ -3.5% |
| 2023 | 0.15x | GBX6.77 Billion | GBX46.21 Billion | ▼ -1.0% |
| 2022 | 0.15x | GBX7.40 Billion | GBX50.05 Billion | ▲ +7.4% |
| 2021 | 0.14x | GBX7.95 Billion | GBX57.76 Billion | ▼ -2.8% |
| 2020 | 0.14x | GBX8.44 Billion | GBX59.62 Billion | ▲ +8.3% |
| 2019 | 0.13x | GBX8.02 Billion | GBX61.34 Billion | ▼ -15.5% |
| 2018 | 0.15x | GBX8.42 Billion | GBX54.39 Billion | ▲ +18.4% |
| 2017 | 0.13x | GBX6.92 Billion | GBX52.89 Billion | ▲ +8.9% |
| 2016 | 0.12x | GBX6.50 Billion | GBX54.12 Billion | ▲ +108.3% |
| 2015 | 0.06x | GBX2.57 Billion | GBX44.57 Billion | ▼ -60.2% |
| 2014 | 0.14x | GBX5.18 Billion | GBX35.72 Billion | ▼ -31.2% |
| 2013 | 0.21x | GBX7.22 Billion | GBX34.27 Billion | ▲ +67.3% |
| 2012 | 0.13x | GBX4.38 Billion | GBX34.73 Billion | ▼ -35.0% |
| 2011 | 0.19x | GBX6.25 Billion | GBX32.25 Billion | ▼ -7.9% |
| 2010 | 0.21x | GBX6.80 Billion | GBX32.31 Billion | ▼ -13.8% |
| 2009 | 0.24x | GBX7.84 Billion | GBX32.12 Billion | ▲ +3.8% |
| 2008 | 0.24x | GBX7.31 Billion | GBX31.07 Billion | ▼ -14.4% |
| 2007 | 0.27x | GBX5.79 Billion | GBX21.09 Billion | ▲ +10.4% |
| 2006 | 0.25x | GBX3.96 Billion | GBX15.90 Billion | ▼ -12.6% |
| 2005 | 0.28x | GBX5.59 Billion | GBX19.63 Billion | ▲ +1.6% |
| 2004 | 0.28x | GBX4.77 Billion | GBX17.01 Billion | ▼ -11.1% |
| 2003 | 0.32x | GBX4.85 Billion | GBX15.40 Billion | ▲ +53.9% |
| 2002 | 0.20x | GBX3.06 Billion | GBX14.94 Billion | ▼ -39.7% |
| 2001 | 0.34x | GBX4.61 Billion | GBX13.57 Billion | ▲ +131.7% |
| 2000 | 0.15x | GBX1.85 Billion | GBX12.63 Billion | ▲ +107.9% |
| 1999 | 0.07x | GBX510.00 Million | GBX7.23 Billion | ▲ +13.1% |
| 1998 | 0.06x | GBX410.00 Million | GBX6.58 Billion | ▼ -33.6% |
| 1997 | 0.09x | GBX615.00 Million | GBX6.55 Billion | ▼ -22.0% |
| 1996 | 0.12x | GBX849.00 Million | GBX7.05 Billion | ▼ -19.9% |
| 1995 | 0.15x | GBX1.25 Billion | GBX8.32 Billion | ▼ -53.7% |
| 1995 | 0.33x | GBX2.45 Billion | GBX7.53 Billion | ▼ -15.4% |
| 1994 | 0.38x | GBX1.05 Billion | GBX2.74 Billion | ▲ +16.2% |
| 1993 | 0.33x | GBX927.00 Million | GBX2.80 Billion | ▲ +2.9% |
| 1992 | 0.32x | GBX657.00 Million | GBX2.04 Billion | ▲ +28.7% |
| 1991 | 0.25x | GBX615.00 Million | GBX2.46 Billion | — |